Ginger
Zingiber officinale rhizome consumed as food, tea, powder, or extract. Preparation changes the relative amounts of gingerols and shogaols, so studies of one product may not generalize to another. Evidence is strongest for selected nausea settings but remains heterogeneous; review medication interactions before concentrated use, particularly with anticoagulant or antiplatelet therapy.
Pharmacokinetic model
A route-level PK model for ginger is being prepared from published data. Dosing references, studies, and documented interactions are below; the app catalog is updated as models are validated.
Key facts
- Category
- Herb
- Suggested cadence
- once daily
Research behind this entry
-
Effects of Ginger Intake on Chemotherapy-Induced Nausea and Vomiting: A Systematic Review of Randomized Clinical Trials
Systematic review of 23 randomized trials found no significant overall difference for acute or delayed nausea or delayed vomiting. A subgroup using no more than 1 g daily for over four days had less acute vomiting, but…
-
Gingerols and shogaols - Important nutraceutical principles from ginger
Narrative review describes gingerol and shogaol chemistry and pharmacology, including conversion during heating and storage. It supports substantial preparation-dependent composition rather than a universal ginger…
-
Ginger extract versus Loratadine in the treatment of allergic rhinitis: a randomized controlled trial.
This citation reports a human clinical study involving Ginger. It does not by itself establish a qualified dose, safety profile, efficacy claim, or pharmacokinetic route for this record.
3 published studies referenced in the app, each with a plain-language summary.